Home - Products - Others - Other Targets - 1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid

1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid

CAS No. 1007999-30-5

1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid ( —— )

Catalog No. M28388 CAS No. 1007999-30-5

1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid is a chemical compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 68 Get Quote
25MG 115 Get Quote
50MG 173 Get Quote
100MG 258 Get Quote
200MG 388 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid is a chemical compound.
  • Description
    1-[(5-chlorothiophen-2-yl)sulfonyl]pyrrolidine-2-carboxylic acid is a chemical compound.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1007999-30-5
  • Formula Weight
    295.8
  • Molecular Formula
    C9H10ClNO4S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)C1CCCN1S(=O)(=O)c1ccc(Cl)s1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cherian MT, et al. CINPA1 is an inhibitor of constitutive androstane receptor that does not activate pregnane X receptor. Mol Pharmacol. 2015 May;87(5):878-89.
molnova catalog
related products
  • Rhodojaponin V

    Antibacterial; anti-inflammatory.

  • Ligustroflavone

    Ligustroflavone has anti-inflammatory activity.

  • Dehydrojuncusol

    Dehydrojuncusol, a new inhibitor of hepatitis C virus RNA replication, it inhibits infection of different HCV genotypes by targeting the NS5A protein and is active against resistant HCV variants frequently found in patients with treatment failure.